Vazirani Asset Management’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-22,000
Closed -$163K – 23
2026
Q1
$163K Sell
22,000
-26,428
-55% -$172K 0.38% 19
2025
Q4
$305K Buy
+48,428
New +$282K 1.85% 10

Vazirani Asset Management's KZR Position: Q2 2026 in Review

Vazirani Asset Management sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 22,000 shares — an estimated $163K sold.

Vazirani Asset Management first reported a position in KZR in Q4 2025 and held it in 2 quarters. The position peaked at $305K in Q4 2025. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

  • Vazirani Asset Management reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Vazirani Asset Management sold 22,000 Kezar Life Sciences shares in Q2 2026, an estimated $163K.
  • Vazirani Asset Management first reported a position in Kezar Life Sciences in Q4 2025 and held it in 2 quarters.
  • Vazirani Asset Management's Kezar Life Sciences position peaked at $305K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Vazirani Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.